Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators. Kimmel SE, et al. Among authors: gage bf. N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251361 Free PMC article. Clinical Trial.
Management and dosing of warfarin therapy.
Gage BF, Fihn SD, White RH. Gage BF, et al. Am J Med. 2000 Oct 15;109(6):481-8. doi: 10.1016/s0002-9343(00)00545-3. Am J Med. 2000. PMID: 11042238 Review.
Pharmacogenetics and anticoagulant therapy.
Gage BF, Eby CS. Gage BF, et al. J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):73-8. doi: 10.1023/B:THRO.0000014598.24114.62. J Thromb Thrombolysis. 2003. PMID: 14760217 Review.
Use of pharmacogenetics to guide warfarin therapy.
Voora D, McLeod HL, Eby C, Gage BF. Voora D, et al. Among authors: gage bf. Drugs Today (Barc). 2004 Mar;40(3):247-57. doi: 10.1358/dot.2004.40.3.820088. Drugs Today (Barc). 2004. PMID: 15148533
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF. Voora D, et al. Among authors: gage bf. Thromb Haemost. 2005 Apr;93(4):700-5. doi: 10.1160/TH04-08-0542. Thromb Haemost. 2005. PMID: 15841315
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Rieder MJ, et al. Among authors: gage bf. N Engl J Med. 2005 Jun 2;352(22):2285-93. doi: 10.1056/NEJMoa044503. N Engl J Med. 2005. PMID: 15930419 Free article.
The pharmacogenetics of coumarin therapy.
Voora D, McLeod HL, Eby C, Gage BF. Voora D, et al. Among authors: gage bf. Pharmacogenomics. 2005 Jul;6(5):503-13. doi: 10.2217/14622416.6.5.503. Pharmacogenomics. 2005. PMID: 16014000 Review.
Genetic-based dosing in orthopedic patients beginning warfarin therapy.
Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF. Millican EA, et al. Among authors: gage bf. Blood. 2007 Sep 1;110(5):1511-5. doi: 10.1182/blood-2007-01-069609. Epub 2007 Mar 26. Blood. 2007. PMID: 17387222 Free PMC article. Clinical Trial.
Optimal initial dose adjustment of warfarin in orthopedic patients.
Lenzini PA, Grice GR, Milligan PE, Gatchel SK, Deych E, Eby CS, Burnett RS, Clohisy JC, Barrack RL, Gage BF. Lenzini PA, et al. Among authors: gage bf. Ann Pharmacother. 2007 Nov;41(11):1798-804. doi: 10.1345/aph.1K197. Epub 2007 Oct 2. Ann Pharmacother. 2007. PMID: 17911206
184 results